Iran's pharmaceutical ambitions are a Catch 22

Iran's pharmaceutical industry has found itself in a catch-22.
On the one hand, the country is trying to grow its pharmaceutical exports and attract investment in the industry. But on the other hand, an increase in output could potentially have a detrimental effect on the price and availability of certain medicines, according to a note from BMI Research.
In order to strengthen the industry, Iran has been turning to other countries and foreign companies for investment. In